Showing results (91-100 of 126) with videos related to

Sort By:
Pageof 13
Cancers|December 11, 2022
Clinical Score to Predict Recurrence in Patients with Stage II and Stage III Colon CancerDavid Viñal, Sergio Martinez-Recio, Daniel Martinez-Perez, et al.
Journal of Geriatric Oncology|October 28, 2020
Undertreatment and overtreatment in older patients treated with chemotherapyJaime Feliu, Enrique Espinosa, Laura Basterretxea, et al.
The Oncologist|June 26, 2019
Prospective Biomarker Study in Advanced RAS Wild-Type Colorectal Cancer: POSIBA Trial (GEMCAD 10-02)Xabier García-Albéniz, Vicente Alonso, Pilar Escudero, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 14, 2005
A panel discussion of controversies and challenges in the adjuvant treatment of colon cancerEduardo Díaz-Rubio García, Albert Abad Esteve, Antonio Antón Torres, et al.
Neoplasia (New York, N.Y.)|May 30, 2018
Coexpression of p-IGF-1R and MMP-7 Modulates Panitumumab and Cetuximab Efficacy in RAS Wild-Type Metastatic Colorectal Cancer PatientsVicente Alonso, Pilar Escudero, Carlos Fernández-Martos, et al.
Investigational New Drugs|May 21, 2017
A phase II study of antibody-drug conjugate, TAK-264 (MLN0264) in previously treated patients with advanced or metastatic pancreatic adenocarcinoma expressing guanylyl cyclase CKhaldoun Almhanna, David Wright, Teresa Macarulla Mercade, et al.
Cancers|May 28, 2022
Identification of Carcinogenesis and Tumor Progression Processes in Pancreatic Ductal Adenocarcinoma Using High-Throughput ProteomicsLucía Trilla-Fuertes, Angelo Gámez-Pozo, María Isabel Lumbreras-Herrera, et al.
Cancer Medicine|December 19, 2019
VITAL phase 2 study: Upfront 5-fluorouracil, mitomycin-C, panitumumab and radiotherapy treatment in nonmetastatic squamous cell carcinomas of the anal canal (GEMCAD 09-02)Jaime Feliu, Rocio Garcia-Carbonero, Jaume Capdevila, et al.
Cancer Biology & Therapy|October 17, 2007
Human recombinant erythropoietin does not promote cancer growth in presence of functional receptors expressed in cancer cellsCristóbal Belda-Iniesta, Rosario Perona, Javier de Castro Carpeño, et al.
Cancer Chemotherapy and Pharmacology|January 16, 2021
Phase II clinical trial of nab-paclitaxel plus gemcitabine in elderly patients with previously untreated locally advanced or metastatic pancreatic adenocarcinoma: the BIBABRAX studyJaime Feliu, Mónica Jorge Fernández, Teresa Macarulla, et al.
Pageof 13